Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Epstein Barr virus volume 1 : one herpes virus: many diseases / / edited by Christian Münz
| Epstein Barr virus volume 1 : one herpes virus: many diseases / / edited by Christian Münz |
| Edizione | [1st ed. 2015.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2015 |
| Descrizione fisica | 1 online resource (387 p.) |
| Disciplina | 616.9940194 |
| Collana | Current Topics in Microbiology and Immunology |
| Soggetto topico | Virology |
| ISBN | 3-319-22822-6 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Preface -- History -- Chap. 1 Why and How Epstein-Barr Virus was discovered 50 years ago - Anthony Epstein, University of Oxford, UK -- Chap. 2. Tumor associations of EBV – historical perspectives - George Klein, Karolinska Institutet, Stockholm, Sweden -- Chap. 3. EBV-specific immune response: early research and personal reminiscences – Denis J. Moss and Viviana P. Lutzky, Queensland Institute of Medical Research, Brisbane, Australia -- Virus genetics and epigenetics -- Chap. 4. Epstein Barr virus strain variation - Paul J. Farrell, Imperial College, London, UK -- Chap. 5. Chromatin Structure of Epstein-Barr Virus Latent Episomes – Paul M. Lieberman, University of Pennsylvania, Philadelphia, USA -- Chap. 6. The epigenetic life cycle of Epstein-Barr virus - Wolfgang Hammerschmidt, Helmholtz Center Munich, Germany. Chap. 7. Epstein-Barr virus: from the detection of sequence polymorphisms to the recognition of viral types - Regina Feederle, Olaf Klinke, Anton Kutikhin, Remy Poirey, Ming-Han Tsai and Henri-Jacques Delecluse, German Cancer Research Center, Heidelberg, Germany -- Viral infection and associated diseases -- Chap. 8. EBV persistence – introducing the virus – David A. Thorley-Lawson, Tufts University, Boston, USA -- Chap. 9. Infectious mononucleosis – Samantha K. Dunmire, Kristin A. Hogquist and Henry H. Balfour, Jr., University of Minnesota, Minneapolis, USA -- Chap. 10. Primary immunodeficiencies associated with EBV disease - Jeffrey I. Cohen, National Institutes of Health, Bethesda, USA -- Chap. 11. Burkitt’s lymphoma – Rosemary Rochford and Ann M. Moormann, University of Massachusetts, Worcester, and Upstate University of New York, Syracuse, USA -- Chap. 12. Contribution of the Epstein-Barr virus to the pathogenesis of Hodgkin lymphoma – Paul Murray and Andrew Bell, University of Birmingham, UK -- Chap. 13. The role of EBV in the pathogenesis of diffuse large B cell lymphoma – Jane A. Healy and Sandeep S. Dave, Duke University, Raleigh, USA -- Chap. 14. Nasopharyngeal carcinoma: an evolving role for the Epstein Barr virus – Nancy Raab-Traub, University of North Carolina, Chapel Hill, USA.-Chap. 15. EBV and autoimmunity – Alberto Ascherio and Kassandra Munger, Harvard University, Boston, USA -- Index. |
| Record Nr. | UNINA-9910298446603321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Epstein Barr Virus Volume 2 : One Herpes Virus: Many Diseases / / edited by Christian Münz
| Epstein Barr Virus Volume 2 : One Herpes Virus: Many Diseases / / edited by Christian Münz |
| Edizione | [1st ed. 2015.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2015 |
| Descrizione fisica | 1 online resource (493 p.) |
| Disciplina | 616.9940194 |
| Collana | Current Topics in Microbiology and Immunology |
| Soggetto topico |
Cancer
Immunology Virology Diseases Biology - Technique Cancer Biology Experimental Organisms |
| ISBN | 3-319-22834-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Preface -- EBV latency -- Chap. 1. EBNA1 – Lori Frappier, University of Toronto, Canada -- Chap. 2. EBNA2 and its coactivator EBNA-LP – Bettina Kempkes, Helmholtz Center Munich, Germany, and Paul D. Ling, Baylor College of Medicine, Houston, USA -- Chap. 3. The EBNA3 family: two oncoproteins and a tumour suppressor that are central to the biology of EBV in B cells– Martin J. Allday, Quentin Bazot and Robert E. White, Imperial College London, UK. Chap. 4. The latent membrane protein 1 (LMP1) – Arnd Kieser and Kai R. Sterz, Helmholtz Center Munich, Germany. Chap. 5. Latent membrane protein 2 (LMP2) – Osman Cen and Richard Longnecker, Northwestern University, Chicago, USA. Chap. 6. EBV non-coding RNAs – Rebecca L. Skalsky and Bryan R. Cullen, Duke University, Durham, USA -- E. Lytic EBV infection -- 7. Viral entry – Liudmila S. Chesnokova, Ru Jiang1 and Lindsey M. Hutt-Fletcher, Louisiana State University, Shreveport, USA -- Chap. 8. Epstein Barr virus lytic cycle reactivation – Jessica McKenzie and Ayman El-Guindy, Yale University, New Haven, USA -- Immune responses to EBV -- Chap. 9. Innate immune recognition of EBV – Anna Lünemann and David Nadal, University of Zürich, Switzerland and Martin Rowe, University of Birmingham, UK -- Chap. 10. Epstein-Barr virus specific humoral immune responses in health and disease – Jaap M. Middeldorp, VU Medical Center, Amsterdam, The Netherlands -- Chap. 11. T cell responses to EBV – Andrew D. Hislop and Graham S. Taylor, University of Birmingham, UK -- Chap. 12. Immune evasion by Epstein Barr virus – Maaike E. Ressing, Michiel van Gent, Anna M. Gram, Marjolein Hooykaas, Sytse Piersma and Emmanuel Wiertz, Utrecht Medical Center, The Netherlands -- Animal models of EBV infection -- Chap. 13. Non-human primate lymphocryptoviruses: past, present, and future– Janine Mühe and Fred Wang, Harvard University, Boston, USA. Chap.14. EBV infection of mice with reconstituted human immune system components – Christian Münz, University of Zürich, Switzerland -- Therapy of EBV associated diseases -- Chap. 15. Adoptive T cell immunotherapy – Stephen Gottschalk and Cliona Rooney, Baylor College of Medicine, Houston, USA -- Chap. 16. The Development of Prophylactic and Therapeutic EBV Vaccines – Corey Smith and Rajiv Khanna, Queensland Institute of Medical Research, Brisbane, Australia -- Chap. 17. The biology and clinical utility of EBV monitoring in blood– Jennifer Kanakry and Richard Ambinder, Johns Hopkins University, Baltimore, USA -- Index. |
| Record Nr. | UNINA-9910298453203321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Harnessing the Participation of Dendritic Cells in Immunity and Tolerance
| Harnessing the Participation of Dendritic Cells in Immunity and Tolerance |
| Autore | Beatriz Boscardin Silvia |
| Pubbl/distr/stampa | Frontiers Media SA, 2020 |
| Descrizione fisica | 1 electronic resource (511 p.) |
| Soggetto topico |
Medicine
Immunology |
| Soggetto non controllato |
dendritic cell
DC subtypes antigen presentation dendritic cell vaccine therapy dendritic cell activation |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557568203321 |
Beatriz Boscardin Silvia
|
||
| Frontiers Media SA, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||